Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort

Introduction: In relapsing Multiple Sclerosis (RMS) patients treated with disease modifying drugs (DMDs), few data are available regarding the biomarkers of treatment response. We aimed to assess the predictive value of lymphocyte count (LC) and Body Mass Index (BMI) for treatment response in a real...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Manni, Alessia, Iaffaldano, Antonio, Lucisano, Giuseppe, D'Onghia, Mariangela, Mezzapesa, Domenico Maria, Felica, Vincenzo, Iaffaldano, Pietro, Trojano, Maria, Paolicelli, Damiano
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2019
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587065/
https://ncbi.nlm.nih.gov/pubmed/31258529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01343
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi